Literature DB >> 8346176

Changes in the gastric mucosa following eradication of Helicobacter pylori.

R M Genta1, G M Lew, D Y Graham.   

Abstract

Although most studies reporting on the examination of Helicobacter pylori infection have focused on the clearance of the bacteria and the rapid disappearance of the neutrophil infiltrates, the evolution of inflammatory and architectural changes in the antral and corporal mucosa following the eradication of H. pylori has not been addressed systematically. This study examines in detail the histopathologic appearance of the antral and corporal mucosa in a group of patients infected with H. pylori and follows the spectrum of morphologic changes in each of them after the eradication of the infection. At least 11 biopsies ("gastric mapping") were obtained from the antrum and body of each of 15 patients with H. pylori. Complete mapping was then repeated 1, 4, and 10 to 12 mo after the eradication of H. pylori by a course of "triple therapy." Each biopsy was assessed in a semi-quantitative fashion for presence of H. pylori, neutrophils, eosinophils, lymphocytes, lymphoid follicles, and intestinal metaplasia. Other features (integrity of surface epithelium, architecture, fibrosis) were evaluated descriptively. Results were compared with those obtained from a control group of 16 uninfected, healthy adult volunteers. H. pylori infection was eradicated in 11 subjects. The disappearance of neutrophils and the normalization of the surface epithelium closely paralleled that of H. pylori. Persistence of even small numbers of neutrophils was a predictor of relapse. Eosinophils and lymphocytes decreased slowly and did not return to normal levels within 1 yr. Lymphoid follicles decreased very slowly in all patients but were still present in all gastric locations at one year after treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8346176

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  43 in total

Review 1.  Biopsy assessment of drug efficacy in the gastrointestinal tract.

Authors:  Marjorie M Walker
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  Regional differences on production of chemokines in gastric mucosa between Helicobacter pylori-positive duodenal ulcer and gastric ulcer.

Authors:  Y Sato; K Sugimura; T Mochizuki; T Honma; H Suriki; K Tashiro; K Ishizuka; R Narisawa; T Ichida; D H Van Thiel; H Asakura
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 3.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 4.  Is intestinal metaplasia of the stomach reversible?

Authors:  M M Walker
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions.

Authors:  J Wang; X Fan; C Lindholm; M Bennett; J O'Connoll; F Shanahan; E G Brooks; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.

Authors:  T Matysiak-Budnik; K Terpend; S Alain; M J Sanson le Pors; J F Desjeux; F Mégraud; M Heyman
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 7.  Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection.

Authors:  Francesco Franceschi; Robert M Genta; Antonio R Sepulveda
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Interobserver variation in histopathological assessment of Helicobacter pylori gastritis.

Authors:  Ozlem Aydin; Reyhan Egilmez; Tuba Karabacak; Arzu Kanik
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

10.  Vacuolating cytotoxin in Helicobacter pylori water-soluble proteins upregulates chemokine expression in human eosinophils via Ca2+ influx, mitochondrial reactive oxygen intermediates, and NF-kappaB activation.

Authors:  Jung Mogg Kim; Joo Sung Kim; Jin Young Lee; Yeong-Jeon Kim; Ho-Joo Youn; In Young Kim; Young Joon Chee; Yu-Kyoung Oh; Nayoung Kim; Hyun Chae Jung; In Sung Song
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.